[Novel molecular therapy for acute promyelocytic leukemia (APL): application of the green tea component, catechin].
Nakazato
Tomonori
T
Kizaki
Masahiro
M
D000818:Animals; D000972:Antineoplastic Agents, Phytogenic / Q000494:pharmacology*; D017209:Apoptosis; D002392:Catechin / Q000031:analogs & derivatives / Q000737:chemistry* / Q000494:pharmacology*; D006801:Humans; D015463:Leukemia, Prolymphocytic / Q000473:pathology*; D051379:Mice; D020411:Oligonucleotide Array Sequence Analysis; D013662:Tea / Q000737:chemistry*; D014407:Tumor Cells, Cultured
D000972:Antineoplastic Agents, Phytogenic; D013662:Tea; D002392:Catechin; C045651:epigallocatechin gallate